provides an epidemiological tool to estimate bone mass in groups of subjects. All our observations were made by a single trained observer, and a formal test of repeatability showed no evidence of systematic variations that could have led to the difference observed.
Three case-control studies using controls from 'the general population, rather than people who had fallen, showed an increase in risk of fracture with reduced Singh grade."-'3 In contrast, two similar studies using dual photon absorptiometry showed only small differences in the bone mineral content of cases and controls.5 14 One interpretation of these findings is that the Singh index reflects some aspect of bone morphology that is more closely related to bone strength than is the bone mineral content as measured by photon absorptiometry.
The study population comprised an unselected series of elderly patients with hip injuries resident in two adjacent health districts. The cases included 92% ofall patients inthe districts who underwent inpatient treatment for hip fracture during the one year study period. The controls were subject to selection by those factors that determine attendance at the casualty department by elderly people who fall and injure their hips. We think it unlikely that these factors are closely related to bone mass and hence it is unlikely that selection bias produced the large differences in the' bone mass of cases and controls.
Three interacting factors may contribute to the risk of hip fracture: bone strength, the risk of falling, and the effectiveness of the neuromuscular responses that protect the skeleton against trauma. Our study was designed to examine two of these factors while allowing for the third. We conclude that at ages below around 75 years reduced bone mass, or osteoporosis, is a strong independent risk factor for fracture. Above that age it may be less important than neuromuscular protective responses. 11 ;Pogrund H, Rigal WM, Makin M, Robin G, Menczel J, Steinberg R. Determination of osteoporosis in patients with fractured femoral neck using the Singh index. Clin Orthop Introduction Despite the availability of a safe measles vaccine for years and the significant reduction in measles in the United States as a result of a statutory immunisation policy' fewer than 600% of children in Britain are currently immunised against the disease.2 This may reflect a lack of concern among some of the health care professions and a misguided tendency in Britain to regard measles as a comparatively mild childhood disease with few sequelae, scarcely worth preventing. Consequently the incidence ofmeasles in Britain is high enough to expose children who are at special risk to a potentially lethal infection. Serious measles infections have long been recognised as a lifethreatening complication of childhood cancer.34 In this group of children the occurrence of severe measles without rash (or with an atypical rash) and presenting as giant cell pneumonia or encephalopathy with a high mortality has been well documented. [3] [4] [5] [6] [7] In view of atypical clinical signs which may occur in immunosuppressed children and the lack ofa comprehensive viral diagnostic service in some hospitals a proportion of unexplained deaths in the past may have been due to unrecognised measles. 8 In order to clarify the serious consequences ofmeasles infection in children having treatment for-cancer Gray et al have reported the experience of four large paediatric oncology units; they found that only three of22 children survived the infection and that one of these was left severely handicapped.9 None ofthe units had the benefit ofa rapid viral diagnostic service during the period of study, and so probably only the most obvious and serious cases were recorded. encephalitis had developed. Though one of these patients (case 16) was exposed to measles over three months before the onset of encephalitic symptoms, her measles complement fixation antibody titre remained undetectable until three weeks after the onset of encephalitis, after which it rose over four weeks to 1/1280. Measles antibody was not detected in cerebrospinal fluid tested during the period when the blood titre began to rise, but none was examined when it was at its maximum.
OTHER CASES
The illness in the remaining children varied from mild to fatal. There was a history of contact with measles in only six of the children, and five were given prophylactic intramuscular immunoglobulin. In the two (cases 9 and 12) not given immunoglobulin the incubation period was normal and both developed a typical measles'rash. In'the three children given immunoglobulin (cases 6, 7, and 15) the incubation periods from time of known contact were 60, 34, and six days, though more recent contact could not be excluded. In cases 7Sand 15 there was a typical rash and both children showed prolonged excretion of virus with persistence of giant cells in the nasopharyngeal secretions. One ofthese patients (case 7), who had pneumonitis, was not examined until three weeks after onset of the rash and giant cells were detected for a further nine days, diminishing after treatment with immunoglobulin.7 In case 6 (included in interferon trial) there was no rash and virus was detected for 13 days. Giant cells were present for six days along with a rhinovirus, but the patient had a good recovery.
FATAL CASES
Of the five patients who died, none had a typical rash. One (case 4) was only six months old and succumbed very rapidly with pneumonitis. Two other patients (cases 2 and 3) were diagnosed late in the illness; both had atypical rashes, which were discrete and macular and mainly confined to the trunk, and severe pneumonitis. In cases 2 and 5 pneumonitis was already present when measles was diagnosed. One child (case 3) had had a fever of unknown origin for 10 days. In these patients giant cells persisted in the nasopharyngeal secretions in undiminishing numbers up to the time of death. Measles specific giant cells were detected in the bronchial secretions in case 2 during life and in the lungs in cases 3 and 5 at necropsy; the virus was isolated throughout the illness and no immune response was detected by complement fixation in any of these patients.
Prolonged excretion of virus was common, as assessed by fluorescent antibody positive cells in serial nasopharyngeal secretions, but in those who survived the numbers of giant cells diminished progressively with a decline in isolation rate. The complement fixation immune response was variable among those tested. The highest titres (1/512 and 1/1280) occurred in patients who developed a delayed encephalitis.
Five children had treatment with immunoglobulin, three with interferon, and four with either interferon or placebo. One patient was given ribavirin by both continuous inhalation and intravenous injection.
Discussion
The mortality from measles in children having treatment positive pressure ventilation it was invariably fatal. Offour patients who died, none had a typical rash or Koplik's spots, and no immune response was detected by complement fixation in the two tested. In normal children with measles giant cells are seldom seen for more than three days after onset of the rash and, though smaller virus infected cells may be detected by the fluorescent antibody technique for longer periods (six to eight days), the virus is seldom isolated after giant cells have disappeared from the secretions.12 This disappearance is usually associated with a detectable immune response. In most of the children in this study who recovered from pneumonitis giant cells persisted for longer than normal, slowly declining until they disappeared, followed by recovery from the illness. Persistence of giant cells in undiminished numbers was the common feature in three ofthe children who died with pneumonitis.
Two constant factors pointed to survival-namely, disappearance of giant cells from nasopharyngeal secretions and a detectable immune response-and three factors together signalled a fatal outcome-namely, persistence of giant cells in undiminished numbers, absence of a typical rash, and absence of a detectable complement fixation immune response.
Encephalitis caused death in one child and severe handicap in another. In the second case interferon may have halted the progress ofan otherwise fatal illness. A similar "arrest" ofan encephalitis was reported in Edinburgh in a child given both intramuscular and intrathecal interferon.'4 In neither case were relevant specimens examined in the period immediately after contact with measles, and so we do not know whether the patients developed an active infection without rash.
BRITISH MEDICAL JOURNAL VOLUME 295 4 JULY 1987 Our study does not provide enough data to decide which treatment, if any, is most beneficial. Neither type of malignancy, nor regimen of treatment, nor age or sex appeared to be particularly associated with the development of measles or its outcome. Despite a few clinically mild cases virological results showed that among those patients from whom serial specimens were obtained only three had truly mild infections, as judged by the detection ofgiant cells for only a briefperiod. Nevertheless, no case ofmeasles should be taken lightly as most are a source of infection to others for a considerable time after onset and a serious danger to other immunocompromised patients.
Measles is also important nationally. Six deaths from measles have so far occurred out of a total of 630 children with acute lymphoblastic leukaemia treated according to the latest MRC UKALL VIII protocol (O B Eden, personal communication). As the survival rate of children with cancer steadily improves deaths from incidental causes such as infection assume greater importance.
How then can children with cancer be protected from measles? Immunisation of immunosuppressed patients with a live attenuated vaccine has been reported from Japan,'5 but its safety has yet to be established. In 1976 Pullan et al suggested that at the initial diagnosis of leukaemia all unimmunised siblings should be given measles immunisation and kept isolated from the patients for two weeks until excretion of the live vaccine had stopped. This may be effective for preschool children, but current emphasis is to encourage children given treatment to lead a normal life, including attendance at both nursery and school, where they may be exposed to many unimmunised children. Fourteen of the 17 children in this study who developed measles did so after the age of 2 years, and all but one of these could have been immunised in the first year of life.
There is no effective treatment for established measles, though interferon and immunoglobulin may be worthy of further study. Ribavirin acts against measles in vitro'6 and when given by inhalation may appreciably shorten the disease in normal children. 17 Early diagnosis is needed so that treatment may be started before severe complications ensue. This means that patients with even apparently mild upper respiratory tract infection, cough, or fever should be investigated for measles. Prophylactic immunoglobulin should certainly be given when a history of contact is known. '8 In the absence of effective treatment eradication of measles by immunisation appears to be the only rational answer. In the United States measles has virtually been eliminated, fewer than 4000 cases a year having been recorded over the past few years. This has been achieved by a system ofcompulsory immunisation, so that over 90% of the population is now immunised.' To eliminate measles from England and Wales 96% ofchildren would have to be immunised by 2 It is not universally acknowledged that eradication of measles is a worthwhile goal,23 but while argument continues children are dying. If a proportion of doctors are so unaware of the dangers of measles that they fail to recommend immunisation and in some cases actively oppose it then it follows that widespread ignorance of the severity of measles is also likely to exist among the public. Most parents questioned on Tyneside were unaware of the symptoms and complications of measles and did not believe immunisation to be effective in preventing the disease.24 Not only does measles immunisation prevent the disease but it has been shown that the workload in general practice related to measles can be reduced by 40%, even when a domiciliary visit is needed to immunise the child. 25 Fifty nine per cent ofchildren born in 1981 in England and Wales had been immunised against measles by the end of 1983.26 For the Northern region 68% of children delivered in 1982 had been immunised against measles whereas 86% had received diphtheria, tetanus, and poliomyelitis vaccine, with an uptake of 98% in some districts-for example, North Tyneside.27 If such a high uptake can be achieved for diseases that are recognised as serious then surely a more widespread recognition of the severe consequences of measles should lead to an increased uptake of the vaccine. There are only two recognised contraindications to measles immunisation namely, cytotoxic or other immunosuppressive treatment, including corticosteroids, and allergy to bacitracin or neomycin.
Every effort must be made to achieve very high acceptance rates for measles immunisation. This can be done only if all health professionals and the public take measles seriously. Until such a change in attitude is achieved it rests with virologists to provide a rapid and adequate diagnostic service and with paediatric oncologists to make the best use of it for the benefit of their patients. Only then will deaths be kept to an absolute minimum.
